Marseille-Kliniken AG

EANS-News: Marseille-Kliniken AG increases result in first quarter 2012/2013

--------------------------------------------------------------------------------
  Corporate news transmitted by euro adhoc. The issuer/originator is solely
  responsible for the content of this announcement.
--------------------------------------------------------------------------------
quarterly report

Subtitle: - EBIT development furthermore continued
- Revenues increased to EUR 50.0 million
- Continuous increase in occupancy rate to currently 90.6 percent

Hamburg, Germany (euro adhoc) - 07 November 2012 - Marseille-Kliniken AG could
further increase its earning potential in the first three months of the current
business year 2012/2013 (01 July 2012 until 30 September 2012). Another
improvement of the occupancy rate to 90.6% (Q1 2011/2012: 88.5%) contributed to
an increase in revenues by 3.7% to EUR 50.0 million (previous year: EUR 48.2
million). As expenditures in areas not directly belonging to care business could
be slightly reduced despite the increased revenues, EBIT amounted to EUR 4.3
million. This means a significant profit improvement against EUR 3.0 million in
the previous year. "We are very pleased with the current development. Anyhow our
core business with the segments inpatient and outpatient care still shows
vacancies of approximately 9%. At this point we see relevant potential which
could not be achieved today, among others because of the general skills shortage
in the nursing care sector", comments Michael Thanheiser, chairman of
Marseille-Kliniken AG.

Marseille-Kliniken AG has built the basis for this continuing upward trend
already in business year 2010/2011 by the implementation of a strategy mix
consisting of focusing on care for the elderly, strengthening of quality
leadership and introduction of a decentralised management structure. This
tendency was confirmed by the currently published quarterly results. Net income
increased to EUR 3.2 million (previous year: EUR 1.5 million), among others
affected by an improved financial result.

Marseille-Kliniken AG sees this result as confirmation of its planning for the
further operational development within the current business year 2012/2013. The
company still expects revenues slightly above previous year's level and an
increase in EBIT.

The complete report on the first three months of business year 2012/2013 such as
additional shareholders' information is available for the public in the investor
relations section on the company's website at www.marseille-kliniken.com.

---- End of press release ----

About Marseille-Kliniken AG:

Marseille-Kliniken AG (ISIN DE0007783003, WKN 778300, MKA) with its 57
residential care facilities, three residential units for assisted living and
about 4,800 employees is a market leading listed company on health care in
Germany. The business model is significantly influenced by the demographic
development. Therefore Marseille-Kliniken AG has a secured future. Short-term
economic fluctuations on the other hand exert only a minor influence. As a
consistently modern company with strong focus on quality, the private enterprise
is in a good position within a competitive environment primarily characterized
by regionally active charities.


Further inquiry note:
Hillermann Consulting
Jan Pahl
Investor Relations for Marseille-Kliniken AG
Poststraße 14-16
20354 Hamburg
Germany
Tel.: +49-(0)40 / 3202791-0
www.marseille-kliniken.com

end of announcement                               euro adhoc 
--------------------------------------------------------------------------------


company:     Marseille-Kliniken AG
             Alte Jakobstraße 79/80
             D-10179 Berlin
phone:       +49 (0)30 246 32-400
FAX:         +49 (0)30 246 32-401
mail:     info@marseille-kliniken.de
WWW:      http://www.marseille-kliniken.de
sector:      Pharmaceuticals
ISIN:        DE0007783003
indexes:     CDAX, Classic All Share, Prime All Share
stockmarkets: free trade: Berlin, Düsseldorf, Stuttgart, regulated dealing:
             Hamburg, regulated dealing/prime standard: Frankfurt 
language:   English
 



Weitere Meldungen: Marseille-Kliniken AG

Das könnte Sie auch interessieren: